ACS Catalysis
(400 MHz, CD2Cl2): δ= 0.30 (s, 9H, CH3, SiMe3), 0.54 (s, 9H,
Page 12 of 17
[Pd(η3-1,3-cyclohexenyl)(L6c)]BF4 (96): 31P NMR (161.9
MHz, CD2Cl2): δ= 143.7 (s). 1H NMR (400 MHz, CD2Cl2): δ=
0.11 (m, 1H, CH2), 0.47 (s, 9H, CH3, SiMe3), 0.54 (s, 9H, CH3,
SiMe3), 0.68 (m, 1H, CH2), 1.0-1.3 (m, 4H, CH2), 1.89 (d, 1H,
1
2
3
4
5
6
7
8
CH3, SiMe3), 4.38 (m, 1H, CH2), 4.47 (m, 1H, CH= trans to N),
5.01 (m, 2H, CH2, CH-N), 5.96 (m, 1H, CHc=), 6.15 (m, 2H,
CH-O, CH= trans to P), 7.10-8.21 (m, 30H, CH=). 13C (100.6
MHz, CD2Cl2): δ= -0.1 (CH3, SiMe3), 0.6 (CH3, SiMe3), 67.7
(CH-N), 67.9 (d, CH= trans to N, JC-P= 10.7 Hz), 76.3 (CH-OP),
78.0 (CH2), 108.1 (d, CH= trans to P, JC-P= 29.8 Hz), 112.6 (d,
CHc=, JC-P= 9.9 Hz), 120.0-150.0 (aromatic carbons), 169.5
(C=N). Minor isomer (25%): 31P NMR (161.9 MHz, CD2Cl2):
δ= 140.2 (s). 1H NMR (400 MHz, CD2Cl2): δ= 0.20 (s, 9H, CH3,
SiMe3), 0.39 (s, 9H, CH3, SiMe3), 4.35 (m, 1H, CH2), 4.74 (m,
1H, CH-N), 5.01 (m, 1H, CH2), 5.23 (m, 1H, CH= trans to N),
5.27 (m, 1H, CH= trans to P), 5.60 (m, 1H, CHc=), 6.15 (m, 1H,
CH-OP), 7.1-8.2 (m, 25H, CH=). 13C (100.6 MHz, CD2Cl2): δ=
-0.5 (CH3, SiMe3), -0.2 (CH3, SiMe3), 68.9 (CH-N), 74.1 (d,
CH= trans to N, JC-P= 10.7 Hz), 75.9 (CH-OP), 77.6 (CH2), 95.9
(d, CH= trans to P, JC-P= 42 Hz), 109.2 (d, CHc=, JC-P= 13.0
Hz), 120.0-150.0 (aromatic carbons), 170.2 (C=N).
3
CH3, JH-H= 6.8 Hz), 4.04 (b, 1H, CH= trans to N), 4.51 (dd,
1H, CH2, 2JH-H= 9.2 Hz, 3JH-H= 8 Hz), 5.15 (dd, 1H, CH2, 2JH-H
=
9.2 Hz, 3JH-H= 10.8 Hz), 5.33 (m, 1H, CHc=), 5.36 (q, 1H, CH,
3JH-H= 6.8 Hz), 5.71 (dd, 1H, CH-N, 3JH-H= 8.0 Hz, 3JH-H= 10.8
Hz), 5.95 (m, 1H, CH= trans to P), 6.99 (d, 1H, CH=, 3JH-H= 8.8
Hz), 7.12 (d, 1H, CH=, 3JH-H= 8.8 Hz), 7.28 (m, 2H, CH=), 7.41-
7.50 (m, 7H, CH=), 8.02 (t, 1H, CH=, 3JH-H= 8.8 Hz), 8.23 (d,
9
1H, CH=, JH-H= 7.2 Hz). 13C (100.6 MHz, CD2Cl2): δ= -0.1
3
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(CH3, SiMe3), 0.0 (CH3, SiMe3), 19.5 (CH2), 22.9 (d, CH3, JC-
P= 4.5 Hz), 27.1 (b, CH2), 67.9 (d, CH= trans to N, JC-P= 9.2
Hz), 71.6 (CH-OP), 74.3 (CH-N), 78.2 (CH2), 104.0 (d, CH=
trans to P, JC-P= 40 Hz), 111.7 (d, CHc=, JC-P= 10.7 Hz), 121.0-
151.0 (aromatic carbons), 171.8 (C=N).
Typical methodology for the allylic alkylation of linear
(S1, S3–S9, S12–S18) and cyclic (S2, S10 and S11)
substrates. A solution of the desired phosphite-oxazoline
ligand (0.011 mmol) and [PdCl(η3-C3H5)]2 (1.8 mg, 0.005
mmol) in CH2Cl2 (0.5 mL) was stirred. After 30 min a solution
of substrate (1 mmol) in CH2Cl2 (1.5 mL), nucleophile (3
mmol), N,O-bis(trimethylsilyl)-acetamide (730 µL, 3 mmol)
and KOAc (3 mg, 0.03 mmol) were subsequently added. After
the desired reaction time the reaction mixture was diluted with
Et2O (5 mL). Saturated NH4Cl (aq) (25 mL) was then added
and the mixture was extracted with Et2O (3 x 10 mL) and the
extract dried over MgSO4. For compounds 20, 22–35, 55–61,
64–69, 72–73 and 82–92, the solvent was evaporated,
conversions were measured by 1H NMR and ees were
calculated by HPLC. For compounds 21, 63, 70–71, 74–75 and
80–81, conversion and ees were determined by GC.5g For
[Pd(η3-1,3-diphenylallyl)(L6c)]BF4 (94): Major isomer
(91%): 31P NMR (161.9 MHz, CD2Cl2): δ= 140.3 (s). 1H NMR
(400 MHz, CD2Cl2): δ= 0.46 (s, 9H, CH3, SiMe3), 0.74 (s, 9H,
3
CH3, SiMe3), 1.96 (d, 3H, CH3, JH-H= 6.8 Hz), 4.33 (dd, 1H,
CH2, 2JH-H= 8.8 Hz, 3JH-H= 4.8 Hz), 4.51 (m, 1H, CH= trans to
N), 4.88 (m, 1H, CH-N), 5.00 (m, 1H, CH2), 5.12 (m, 1H, CH-
OP), 6.02 (m, 2H, CHc=, CH= trans to P), 6.3-8.4 (m, 25H,
CH=). 13C (100.6 MHz, CD2Cl2): δ= -0.1 (CH3, SiMe3), 0.8
(CH3, SiMe3), 22.6 (b, CH3), 67.3 (CH-N), 68.3 (d, CH= trans
to N, JC-P= 9.9 Hz), 71.5 (CH-OP), 78.2 (CH2), 106.8 (d, CH=
trans to P, JC-P= 30.4 Hz), 112.2 (d, CHc=, JC-P= 9.8 Hz), 121.0-
150.0 (aromatic carbons), 172.1 (C=N). Minor isomer (9%): 31
P
NMR (161.9 MHz, CD2Cl2): δ= 142.9 (s). 1H NMR (400 MHz,
CD2Cl2): δ= 0.41 (s, 9H, CH3, SiMe3), 0.62 (s, 9H, CH3, SiMe3),
1.75 (d, 3H, CH3, 3JH-H= 6.8 Hz), 4.39 (dd, 1H, CH2, 2JH-H= 8.8
Hz, 3JH-H= 4.4 Hz), 4.53 (m, 1H, CH= trans to N), 4.71 (m, 1H,
CH2), 4.88 (m, 1H, CH-N), 5.12 (m, 1H, CH-OP), 5.98 (m, 1H,
CH= trans to P), 6.09 (m, 1H, CHc=), 6.3-8.4 (m, 25H, CH=).
13C (100.6 MHz, CD2Cl2): δ= 0.1 (CH3, SiMe3), 0.3 (CH3,
SiMe3), 22.4 (b, CH3), 68.1 (CH-N), 68.4 (d, CH= trans to N,
JC-P= 9.2 Hz), 70.9 (CH-OP), 78.0 (CH2), 98.8 (d, CH= trans to
P, JC-P= 32.4 Hz), 112.7 (d, CHc=, JC-P= 9.2 Hz), 121.0-150.0
(aromatic carbons), 172.3 (C=N).
1
compounds 62 and 79, conversion was measured by H NMR
1
and ees were determined by H NMR using [Eu(hfc)3]. See
Supporting Information for characterization and enantiomeric
excess determination details.
Typical methodology for the allylic amination of S1
and S2. A solution of the desired phosphite-oxazoline ligand
(0.011 mmol) and [PdCl(η3-C3H5)]2 (1.8 mg, 0.005 mmol) in
CH2Cl2 (0.5 mL) was stirred. After 30 min, a solution of
substrate (1 mmol) in CH2Cl2 (1.5 mL) and the corresponding
amine (3 mmol) were subsequently added. After the desired
reaction time the reaction mixture was diluted with Et2O (5
mL). Saturated NH4Cl (aq) (25 mL) was then added and the
mixture was extracted with Et2O (3 x 10 mL) and the extract
dried over MgSO4. Conversions were determined by 1H NMR.
HPLC was employed to calculate enantiomeric excesses of
compounds 36–47 and 76–78. See Supporting Information for
characterization and enantiomeric excess determination details.
[Pd(η3-1,3-cyclohexenyl)(L2c)]BF4 (95): Major isomer
(95%): 31P NMR (161.9 MHz, CD2Cl2): δ= 143.3 (s). 1H NMR
(400 MHz, CD2Cl2): δ= 0.03 (s, 9H, CH3, SiMe3), 0.10 (m, 1H,
CH2), 0.61 (s, 9H, CH3, SiMe3), 0.81 (m, 1H, CH2), 1.0-1.3 (m,
4H, CH2), 4.05 (b, 1H, CH= trans to N), 4.53 (m, 1H, CH2),
5.18 (m, 1H, CH2), 5.33 (m, 1H, CHc=), 5.95 (m, 1H, CH-N),
6.09 (m, 1H, CH= trans to P) 6.36 (d, 1H, CH-OP, JC-P= 26.0
Hz), 7.10 (d, 1H, CH=, 3JH-H= 8.8 Hz) , 7.11-7.30 (m, 2H, CH=),
3
7.42-7.60 (m, 14H, CH=), 8.02 (d, 2H, CH=, JH-H= 8.4 Hz),
8.24 (s, 1H, CH=). 13C (100.6 MHz, CD2Cl2): δ= -0.4 (CH3,
SiMe3), 0.0 (CH3, SiMe3), 19.9 (CH2), 27.0 (b, CH2), 68.5 (d,
CH= trans to N, JC-P= 9.1 Hz), 74.5 (CH-OP), 76.4 (CH-N),
78.2 (CH2), 104.4 (d, CH= trans to P, JC-P= 39.5 Hz), 111.6 (d,
CHc=, JC-P= 10.7 Hz), 122.7-151.0 (aromatic carbons), 169.4
(C=N). Minor isomer (5%): 31P NMR (161.9 MHz, CD2Cl2): δ=
Typical methodology for the allylic etherification and
silylation of S1. A solution of the desired phosphite-oxazoline
ligand (0.011 mmol) and [PdCl(η3-C3H5)]2 (1.8 mg, 0.005
mmol) in CH2Cl2 (0.5 mL) was stirred. After 30 min, a solution
of S1 (31.5 mg, 0.125 mmol) in CH2Cl2 (1.5 mL) was added.
After 10 min, Cs2CO3 (122 mg, 0.375 mmol) and the
corresponding alkyl alcohol or silanol (0.375 mmol) were
added. . After the desired reaction time, the reaction mixture
was diluted with Et2O (5 mL). Saturated NH4Cl (aq) (25 mL)
was then added and the mixture was extracted with Et2O (3 x
10 mL) and the extract dried over MgSO4. Conversions were
1
139.5 (s). H NMR (400 MHz, CD2Cl2): δ= 0.08 (s, 9H, CH3,
SiMe3), 0.10 (m, 1H, CH2), 0.61 (s, 9H, CH3, SiMe3), 0.81 (m,
1H, CH2), 1.0-1.3 (m, 4H, CH2), 3.94 (b, 1H, CH= trans to N),
4.53 (m, 1H, CH2), 5.21 (m, 2H, CH2, CHc=), 5.95 (m, 2H, CH=
trans to P, CH-N), 6.34 (d, 1H, CH-OP, JC-P= 21.0 Hz), 7.0-8.2
(m, 20H, CH=).
1
determined by H NMR. HPLC was employed to calculate
ACS Paragon Plus Environment